● ImportantWorld10 outlets covering this

A new flu vaccine geared to older people is coming soon

● Story signals

How strong is this topic?

8.2/10Significanceimpact & urgency
7.3/10Source trustoutlet authority
10Outletsindependent sources

Significance weighs impact, urgency & coverage breadth · Source trust is the outlets' average authority · more outlets means a more confirmed story.

Answer

The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker(Image credit: Marco Bello/Bloomberg)

Reported by 10 outlets NPR Health, CBS News, The Guardian US, ABC News, Ars Technica, and 4 more. See all sources ↓

Read the full report at NPR Health

Why it matters

10 outlets are covering this world story — one to watch as reporting develops.

In brief
What's the story?
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker(Image credit: Marco Bello/Bloomberg)
How widely is it covered?
10 outlets, average source rating 7.3/10.
When was it last updated?
15m ago.
Different angles across outlets
Coverage map

How outlets are framing the same story

Here's how each outlet is covering the story — compare their headlines and timing at a glance.

  • Coverage card9 outlets
    1Coverage
    Scouting report

    New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine

    Sources9
    TypeCoverage
    NPR Health
    CBS News
    The Guardian US
    ABC News
    Ars Technica
    CNBC Top News
    The Hill
    Fox News Latest
    Seattle Times
Related in the knowledge graph
Sources (10)
Avg source rating 7.3/10
Processing cluster
A1A2A3B1B2B3
Share this article
Summarize with AI (opens AI chat with article URL · Gemini: prompt copied to clipboard)